What is SLGL's P/E ratio?

Sol Gel Technologies LTD (SLGL) currently trades at a P/E ratio of 23.99.

Sol Gel Technologies LTD reports a Return on Equity (ROE) of -2.03%.

What is SLGL's dividend yield?

Sol Gel Technologies LTD offers a dividend yield of 0.00%.

What is SLGL's Quality Score?

Our AI rates SLGL's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy SLGL?

Our AI Timing Score for SLGL is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does SLGL belong to?

Sol Gel Technologies LTD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Sol Gel Technologies LTD (SLGL) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

SLGL AI Analysis Summary

Our AI summary for SLGL: Sol Gel Technologies LTD (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 23.99, ROE of -2.03%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SLGL

Sol Gel Technologies LTD

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 82.25

-2.94 (-3.45%) Day Change

Watchlist Portfolio Compare Chart

23.99

P/E

0.01

D/E

-2.0%

ROE

-1.8%

ROA

0.00%

Div Yield

0.15

PEG

SOL GEL TECHNOLOGIES LTD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 82.25 Price -2.94 (-3.45%) Day Change	NEWS SCORE: 91

SLGL, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	82.25
PBV / Sector	5.42 / 5.20
Earning Per Share	-0.31

PE / Sector	23.99 / 19.97
PEG or PE/Growth / Sector	0.15 / 1.22 GREAT
Average 1M Daily Value	3.54 M GREAT
Average 1W Daily Value	4.44 M GREAT

Timing Factors

85%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-5.66 / 98.71
NPM Average (%) / Sector	-453.21 / -1,721.76
NPM Change Average (%) / Sector	28.42 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-1.79 / 27.02
ROA Average (%) / Sector	-28.79 / -368.17
ROA Change Average (%) / Sector	-21.22 / 5,404.12
ROE (%) / Sector	-2.03 / 3.47
ROE Average (%) / Sector	-34.28 / 6.51
ROE Change Average (%) / Sector	-16.94 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:29
Symbol	SLGL
Name	SOL GEL TECHNOLOGIES LTD
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	3.27 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	278.49 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 7 Golda Meir Street, Ness Ziona, Israel, 7403650

Phone: 972 8 931 3433

Website: https://www.sol-gel.com

Sector: Healthcare >> Biotechnology

Description: Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.